MedTrace Logo

Avenir Müller Hip Stem Post Market Surveillance Study

NCT04079127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-05-14

Study results available
· View outcomes & findings →

Summary

This study is a Post Market Clinical Follow up study to fulfil the post market surveillance obligations according to Medical Device Directive and European Medical Device Vigilance System (MEDDEV) 2.12-2. The data collected from this study will serve the purpose of confirming safety and performance of the Avenir Müller Hip Stem.

Conditions

  • Osteoarthritis, Hip
  • Rheumatoid Arthritis
  • Fracture of Hip
  • Dislocated Hip
  • Osteonecrosis
  • Post-traumatic; Arthrosis
  • Subluxation Hip

Interventions

DEVICE

Patients who met the inclusion/exclusion criteria to receive the Avenir Müller stem.

Consecutive cohort of patients enrolled at every site who received the Avenir Müller stem.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Paola Vivoda · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-09
Primary Completion
2019-06-29
Completion
2019-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04079127 on ClinicalTrials.gov